These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15795718)

  • 1. Parenteral dihydroergotamine for acute migraine headache: a systematic review of the literature.
    Colman I; Brown MD; Innes GD; Grafstein E; Roberts TE; Rowe BH
    Ann Emerg Med; 2005 Apr; 45(4):393-401. PubMed ID: 15795718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relative efficacy of meperidine for the treatment of acute migraine: a meta-analysis of randomized controlled trials.
    Friedman BW; Kapoor A; Friedman MS; Hochberg ML; Rowe BH
    Ann Emerg Med; 2008 Dec; 52(6):705-13. PubMed ID: 18632186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic treatment of migraine in children: a systematic review of medication trials.
    Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
    Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache.
    Edwards KR; Norton J; Behnke M
    Headache; 2001; 41(10):976-80. PubMed ID: 11903525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroergotamine: role in the treatment of migraine.
    Schürks M
    Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.
    Winner P; Dalessio D; Mathew N; Sadowsky C; Turkewitz LJ; Sheftell F; Silberstein SD; Solomon S
    Am J Emerg Med; 1994 Mar; 12(2):138-41. PubMed ID: 8161382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, multicenter trial to compare the efficacy of intramuscular dihydroergotamine plus hydroxyzine versus intramuscular meperidine plus hydroxyzine for the emergency department treatment of acute migraine headache.
    Carleton SC; Shesser RF; Pietrzak MP; Chudnofsky CR; Starkman S; Morris DL; Johnson G; Rhee KJ; Barton CW; Chelly JE; Rosenberg J; Van Valen MK
    Ann Emerg Med; 1998 Aug; 32(2):129-38. PubMed ID: 9701293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials.
    Colman I; Brown MD; Innes GD; Grafstein E; Roberts TE; Rowe BH
    BMJ; 2004 Dec; 329(7479):1369-73. PubMed ID: 15550401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketorolac in the treatment of acute migraine: a systematic review.
    Taggart E; Doran S; Kokotillo A; Campbell S; Villa-Roel C; Rowe BH
    Headache; 2013 Feb; 53(2):277-87. PubMed ID: 23298250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroergotamine: a review of its use in the treatment of migraine and other headaches.
    Scott AK
    Clin Neuropharmacol; 1992 Aug; 15(4):289-96. PubMed ID: 1516074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications.
    Kelley NE; Tepper DE
    Headache; 2012 Mar; 52(3):467-82. PubMed ID: 22404708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.
    Aurora SK; Silberstein SD; Kori SH; Tepper SJ; Borland SW; Wang M; Dodick DW
    Headache; 2011 Apr; 51(4):507-17. PubMed ID: 21457235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety, and tolerability of dihydroergotamine nasal spray as monotherapy in the treatment of acute migraine. Dihydroergotamine Nasal Spray Multicenter Investigators.
    Headache; 1995 Apr; 35(4):177-84. PubMed ID: 7775172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute Treatment Therapies for Pediatric Migraine: A Qualitative Systematic Review.
    Patniyot IR; Gelfand AA
    Headache; 2016 Jan; 56(1):49-70. PubMed ID: 26790849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprepitant for the management of nausea with inpatient IV dihydroergotamine.
    Chou DE; Tso AR; Goadsby PJ
    Neurology; 2016 Oct; 87(15):1613-1616. PubMed ID: 27629088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous dihydroergotamine for inpatient management of refractory primary headaches.
    Nagy AJ; Gandhi S; Bhola R; Goadsby PJ
    Neurology; 2011 Nov; 77(20):1827-32. PubMed ID: 22049203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current emergency treatment of severe migraine headaches.
    Klapper JA; Stanton J
    Headache; 1993; 33(10):560-2. PubMed ID: 8294195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of intravenous diphenhydramine versus intravenous DHE-45 in the treatment of severe migraine headache.
    Swidan SZ; Lake AE; Saper JR
    Curr Pain Headache Rep; 2005 Feb; 9(1):65-70. PubMed ID: 15625028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Office-based treatment of acute migraine with dihydroergotamine mesylate.
    Winner P; Dalessio D; Mathew N; Sadowsky C; Turkewitz LJ; Sheftell F; Silberstein SD; Solomon S
    Headache; 1993 Oct; 33(9):471-5. PubMed ID: 8262792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of migraine attacks: combination of dihydroergotamine tartrate and paracetamol in comparison with individual drugs and placebo].
    Hoernecke R; Doenicke A
    Med Klin (Munich); 1993 Nov; 88(11):642-8. PubMed ID: 8295604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.